Suzhou Otovia Therapeutics Co., Ltd.
PrivateLast Round
VC Round
Jan 4, 2026
Company Overview
Suzhou Otovia Therapeutics Co., Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a VC Round in January 2026.
Suzhou Otovia Therapeutics Co., Ltd. is a biotechnology company that develops AAV-based gene therapies for the treatment of hearing loss and related neurodegenerative conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Suzhou Otovia Therapeutics Co., Ltd. Comparables
Compare Suzhou Otovia Therapeutics Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Skylark Bio | 86% | |
| Shanghai Refreshgene Technology Co., Ltd. | 81% | |
| Eli Lilly and Company | 79% |
For institutional investors. Book with your work email.
Suzhou Otovia Therapeutics Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 4, 2026 | ||||
| Angel | Jan 1, 2022 |
For institutional investors. Book with your work email.
Suzhou Otovia Therapeutics Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dingxin Capital | VC Round |
| 南京市创新投资集团有限责任公司 | VC Round |
Suzhou Otovia Therapeutics Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Suzhou Otovia Therapeutics Co., Ltd.'s valuation, stock price, and market status.
Is Suzhou Otovia Therapeutics Co., Ltd. a public or private company?
Suzhou Otovia Therapeutics Co., Ltd. is a private company.
What is the current stock price of Suzhou Otovia Therapeutics Co., Ltd.?
Suzhou Otovia Therapeutics Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Suzhou Otovia Therapeutics Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Suzhou Otovia Therapeutics Co., Ltd. worth (valuation)?
Valuation information for Suzhou Otovia Therapeutics Co., Ltd. is not publicly available.
Can I buy Suzhou Otovia Therapeutics Co., Ltd. stock?
Suzhou Otovia Therapeutics Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Suzhou Otovia Therapeutics Co., Ltd.'s last funding round?
Suzhou Otovia Therapeutics Co., Ltd.'s most recent funding round was VC Round on January 4, 2026.
Who are the main investors in Suzhou Otovia Therapeutics Co., Ltd.?
Key investors in Suzhou Otovia Therapeutics Co., Ltd. include Dingxin Capital, 南京市创新投资集团有限责任公司.
Will Suzhou Otovia Therapeutics Co., Ltd. IPO soon?
No public IPO plans have been announced for Suzhou Otovia Therapeutics Co., Ltd..
How can I track Suzhou Otovia Therapeutics Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Suzhou Otovia Therapeutics Co., Ltd.'s shares on secondary markets.